A European update on transcatheter aortic valve implantation (TAVI) in the COVID era

Abstract

Minimally invasive approaches for aortic valve replacement are now at the forefront of pathological aortic valve treatment. New trials show comparability of these devices to existing therapies, not only in high-risk surgical cohorts but also in low-risk and intermediate-risk cohorts. This review provides vital clinical and anatomical background to aortic valvular disease treatment guidelines, while also providing an update on transcatheter aortic valve implantation (TAVI) devices in Europe, their interventional trials and associated complications.

Keywords: aortic valve disease; aortic valve prosthesis; device clinical trials; transcatheter aortic valve implantation; transcatheter aortic valve replacment.